|
Purine Nucleoside
|
|
ILX:0109543
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Purine Nucleotide
|
|
ILX:0109544
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Purkinje cell layer of cerebellar cortex
|
A cell layer of the cerebellar cortex, characterized by a single sheet of very large, bottle-shaped Purkinje neurons that are regularly spaced and possess flattened fanlike dendritic arborizations, lying deep to the molecular layer and superficial to the granule cell layer.
|
ILX:0109545
|
11
|
FDI Lab - SciCrunch.org
|
11/30/2020
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Purple
|
A color that falls about midway between red and blue in hue.
|
ILX:0109546
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Purpose of Reference Code Sequence
|
Code describing the purpose of the reference to the Instance(s).
|
ILX:0109547
|
5
|
FDI Lab - SciCrunch.org
|
08/28/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
troy sincomb |
|
Pursuit rotor task
|
The pursuit rotor task is a task used in common use in the mid 20th century which involved a participant trying to follow (pursue) a small disc on a rotating turntable. Original mechanical versions had typical rotation rates of 60 RPM, which is probably too fast for mouse-controlled versions. The PEBL version offers a simple version with multiple trials and controllable parameters that can be used as a test of hand-eye coordination.
|
ILX:0109548
|
4
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Putamen
|
Subcortical nucleus of telencephalon , which together with the caudate nucleus, forms the striatum. The putamen lies lateral to the internal capsule and medial to the external medullary lamina, and is separated from the caudate nucleus by the fibers of the internal capsule for most of its length, except at its anterior portion.
|
ILX:0109549
|
10
|
FDI Lab - SciCrunch.org
|
01/17/2023
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Putamen of PHT00
|
|
ILX:0109550
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
PVC Rejection
|
Description of type of PVC rejection criteria used.
|
ILX:0109551
|
4
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Pyramid
|
White matter structure at the base of the medulla containing the axons of the corticospinal tract (MM)
|
ILX:0109552
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Pyramidal
|
Generally triangular-shaped soma with a dendrite emerging from the apical pole and basilar dendrites emerging from two or more basal poles
|
ILX:0109553
|
4
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Pyramidal decussation
|
Part of medulla comprising a white matter structure containing nerve fibers of the pyramidal tract crossing from one side of the brain to the other (MM)
|
ILX:0109554
|
11
|
FDI Lab - SciCrunch.org
|
11/30/2020
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Pyramidal Neuronal Cell Body
|
|
ILX:0109555
|
4
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Pyramidal tract
|
Tract of brain, each instance of which is a collection of some corticospinal and cortibulbar nerve fibers that crossover at the level of the pyramids in some medulla oblongata; it is a collection of some upper motor neuron fibers which go to some spinal cord (corticospinal) or some brainstem (corticobulbar) and control the motor function of some body.
|
ILX:0109556
|
13
|
FDI Lab - SciCrunch.org
|
01/17/2023
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Pyramids and palm trees task
|
a semantic memory test that presents one word or picture above two others. The participant is then asked to identify which of the bottom items best matches the top item. Semantic memory is necessary for the identification of the analogies, which link conceptually two perceptually, and functionally distinct entities.
|
ILX:0109557
|
4
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Pyramus (VIII) of ABA 2009
|
|
ILX:0109558
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Pyrazinamide
|
A pyrazine that is used therapeutically as an antitubercular agent. (PubChem) Pharmacology: Pyrazinamide kills or stops the growth of certain bacteria that cause tuberculosis (TB). It is used with other drugs to treat tuberculosis. It is a highly specific agent and is active only against Mycobacterium tuberculosis. In vitro and in vivo, the drug is active only at a slightly acid pH. Mechanism of action: Pyrazinamide is an important sterilizing drug that shortens tuberculosis (TB) therapy. However, the mechanism of action of pyrazinamide is poorly understood because of its unusual properties. In literature it has been written that the pyrazinoic acid (POA), the active moiety of pyrazinamide, disrupted membrane energetics and inhibited membrane transport function at acid pH in Mycobacterium tuberculosis. The antimycobacterial activity appears to partly depend on conversion of the drug to POA. Susceptible strains of M. tuberculosis produce pyrazinamidase, an enzyme that deaminates pyrazinamide to POA, and the vitro susceptibility of a given strain of the organism appears to correspond to its pyrazinamidase activity. Experimental evidence suggests that pyrazinamide diffuses into M. tuberculosis in a passive manner, is converted into POA by pyrazinamidase, and because of an inefficient efflux system, accumulates in huge amounts in the bacterial cytoplasm. The accumulation of POA lowers the intracellular pH to a suboptimal level that is likely to inactivate a vital target enzyme such as fatty acid synthase. Drug type: Approved. Small Molecule. Drug category: Antitubercular Agents
|
ILX:0109559
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |
|
Pyridostigmine
|
A cholinesterase inhibitor with a slightly longer duration of action than neostigmine. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants. (PubChem) Pharmacology: Pyridostigmine is a parasympathomimetic and a reversible cholinesterase inhibitor. Since it is a quaternary amine, it is poorly absorbed in the gut and doesn't cross the blood-brain barrier. Pyridostigmine has a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants. Mechanism of action: Pyridostigmine inhibits acetylcholinesterase in the synaptic cleft by competing with acetylcholine for attachment to acetylcholinesterase, thus slowing down the hydrolysis of acetylcholine, and thereby increases efficiency of cholinergic transmission in the neuromuscular junction and prolonges the effects of acetylcholine. Drug type: Approved. Small Molecule. Drug category: Antimyasthenics. Cholinesterase Inhibitors. Parasympathomimetics
|
ILX:0109560
|
4
|
FDI Lab - SciCrunch.org
|
08/24/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
troy sincomb |
|
Pyridoxal
|
The 4-carboxyaldehyde form of vitamin B 6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. (PubChem) Pharmacology: Pyridoxal principally in the form of the coenzyme pyridoxal 5'-phosphate, is involved in a wide range of biochemical reactions, including the metabolism of amino acids and glycogen, the synthesis of nucleic acids, hemogloblin, sphingomyelin and other sphingolipids, and the synthesis of the neurotransmitters serotonin, dopamine, norepinephrine and gamma-aminobutyric acid (GABA). Mechanism of action: Pyridoxal is the precursor to pyridoxal phosphate. Pyridoxal 5'-phosphate is involved in a wide range of biochemical reactions, including the metabolism of amino acids and glycogen, the synthesis of nucleic acids, hemogloblin, sphingomyelin and other sphingolipids, and the synthesis of the neurotransmitters serotonin, dopamine, norepinephrine and gamma-aminobutyric acid (GABA). Drug type: Approved. Nutraceutical. Small Molecule. Drug category: Dietary supplement. Micronutrient. Vitamin B Complex. Vitamins (Vitamin B Complex)
|
ILX:0109561
|
4
|
FDI Lab - SciCrunch.org
|
08/24/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
troy sincomb |
|
Pyridoxal Phosphate
|
This is the active form of vitamin B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (pyridoxamine). (PubChem) Pharmacology: The two major forms of vitamin B6 are pyridoxine and pyridoxamine. In the liver they are converted to pyridoxal phosphate (PLP) which is a cofactor in many reactions of amino acid metabolism. PLP also is necessary for the enzymatic reaction governing the release of glucose from glycogen. Pyroluria is one potential cause of vitamin B6 deficiency. Mechanism of action: Pyridoxal Phosphate is a coenzyme of many enzymatic reactions. It is the active form of vitamin B6 which comprises three natural organic compounds, pyridoxal, pyridoxamine and pyridoxine. Pyridoxal phosphate acts as a coenzyme in all transamination reactions, and in some decarboxylation and deamination reactions of amino acids. The aldehyde group of pyridoxal phosphate forms a Schiff-base linkage with the epsilon-amino group of a specific lysine group of the aminotransferase enzyme. The alpha-amino group of the amino acid substrate displaces the epsilon-amino group of the active-site lysine residue. The resulting aldimine becomes deprotonated to become a quinoid intermediate, which in turn accepts a proton at a different position to become a ketimine. The resulting ketimine is hydrolysed so that the amino group remains on the protein complex. Drug type: Small Molecule. Drug category: Dietary supplement. Micronutrient. Vitamin B Complex
|
ILX:0109562
|
3
|
FDI Lab - SciCrunch.org
|
06/18/2018
|
FDI Lab - SciCrunch.org |
term |
12/09/2016 |
0 |
NeuroLex |
NeuroLex |